FMP
NASDAQ
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
2.79 USD
-0.12 (-4.3%)
Ms. Maria Zannes J.D.
Healthcare
Medical - Diagnostics & Research
https://www.bioaffinitytech.com
NASDAQ
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
0001712762
US09076W1099
N/A
22211 West Interstate 10
210 698 5334
US
14
Sep 1, 2022
0001712762
NASDAQ
Medical - Diagnostic...
Healthcare
-
US09076W1099
US
2.79
3.99
213.7k
32.13M
-
0.955-3.62
0.14
-
-
-
-
-3.07
-
https://www.bioaffinitytech.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.